The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-19-Reference-Cited by-同舟云学术

The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-19

Published:2024-02-02 Issue: Volume: Page:1-9
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Chang Wen-Kuei¹²³,Wang Chieh-Jen¹³^ORCID,Tsai Tung-Hu²⁴⁵⁶,Sun Fang-Ju⁷,Chen Chao-Hsien³⁸^ORCID,Kuo Kuan-Chih¹³,Chung Hsin-Pei¹³,Tang Yen-Hsiang³⁹,Chen Yen-Ting¹³,Wu Kuo-Lun¹,Wu Jou-Chun¹,Lin Chang-Yi¹³,Zhang Hai-Bo¹⁰

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan

2. Institute of Traditional Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

3. Department of Medicine, MacKay Medical College, New Taipei, Taiwan

4. Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan

5. Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan

6. School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

7. Department of Medical Research, MacKay Memorial Hospital, New Taipei, Taiwan

8. Division of Pulmonary Medicine, Department of Internal Medicine, Taitung MacKay Memorial Hospital, Taitung, Taiwan

9. Department of Critical Care Medicine, MacKay Memorial Hospital, Taipei, Taiwan

10. Anesthesia, Medicine and Physiology, University of Toronto, Toronto, Canada

Funder

no funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2313054

Reference33 articles.

1. WHO. Living guidance for clinical management of COVID-19. [cited 2021 January 25]. Available from: https://iris.who.int/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pdf?fbclid=IwAR12xT-xnppVdLzVz37rnlHAC66kJQ2i6iKfx3o5rhVo0a4dTXgndRMOUt4

2. A living WHO guideline on drugs for covid-19

3. Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis

4. Flawed ivermectin preprint highlights challenges of COVID drug studies

5. Efficacy of early treatment with hydroxychloroquine in people with mild to moderate COVID-19: A systematic review and meta-analysis